Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Other Operating Expenses: 2020-2025

Historic Other Operating Expenses for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Sep 2025 value amounting to $60,000.

  • Maravai Lifesciences Holdings' Other Operating Expenses fell 99.96% to $60,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $284.0 million, marking a year-over-year increase of 8.59%. This contributed to the annual value of $315.0 million for FY2024, which is 116.58% up from last year.
  • As of Q3 2025, Maravai Lifesciences Holdings' Other Operating Expenses stood at $60,000, which was down 99.91% from $70.2 million recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Other Operating Expenses registered a high of $162.2 million during Q4 2024, and its lowest value of $60,000 during Q3 2025.
  • For the 3-year period, Maravai Lifesciences Holdings' Other Operating Expenses averaged around $59.9 million, with its median value being $39.1 million (2023).
  • Per our database at Business Quant, Maravai Lifesciences Holdings' Other Operating Expenses spiked by 947.26% in 2021 and then crashed by 99.96% in 2025.
  • Maravai Lifesciences Holdings' Other Operating Expenses (Quarterly) stood at $39.1 million in 2021, then surged by 36.06% to $53.3 million in 2022, then slumped by 40.37% to $31.8 million in 2023, then soared by 410.69% to $162.2 million in 2024, then tumbled by 99.96% to $60,000 in 2025.
  • Its Other Operating Expenses was $60,000 in Q3 2025, compared to $70.2 million in Q2 2025 and $51.6 million in Q1 2025.